Get started
Author

Daniel Gabovitch

Observed name: DANIEL GABOVITCH
ORCID: 0009-0007-5854-4392
Observed ORCID: 0009-0007-5854-4392
OpenAlex ID: A5038207150
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE Trial
2024 · Alexander J. Blood, Lee-Shing Chang, et al. · Circulation · 32
The Long-Term Blood Pressure Trends Following a Remote Hypertension Intervention: A Secondary Analysis of the Digital Care Transformation - Remotely Delivered Hypertension Management Program
2025 · Shahzad Hassan, Alexander J. Blood, et al. · Hypertension · 8
Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension Management
2025 · Ozan Unlu, Christopher P Cannon, et al. · American Journal of Hypertension · 8
PDF
Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies
2025 · Alexander J. Blood, Lee-Shing Chang, et al. · American Heart Journal · 7
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney risk
2024 · Alexander J. Blood, Lee-Shing Chang, et al. · Primary care diabetes · 7
PDF
Enrollment strategies in the era of digital revolution: Experience from a remote health management program
2024 · Shahzad Hassan, Lee-Shing Chang, et al. · American Heart Journal · 4
172-OR: Eligibility and Utilization of SGLT2i and GLP1-RA in T2D by Cardiovascular and Renal Indications
2022 · ALEXANDER BLOOD, LEE-SHING CHANG, et al. · Diabetes · 3
Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure
2026 · Alexander J. Blood, Ozan Unlu, et al. · Clinical Cardiology · 2
Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney risk
2026 · Lee-Shing Chang, Shahzad Hassan, et al. · American Heart Journal · 1
Abstract 16521: Using Electronic Health Record Data to Identify and Prioritize Patients With Heart Failure With Reduced Ejection Fraction for a Remote Medication Optimization Program
2023 · Ozan Unlu, Alexander J Blood, et al. · Circulation · 1
A Remote Program for Navigator‐ and Pharmacist‐Led Management of Obesity Medications in Adults: Rationale, Design, and Implementation
2026 · Bryn Falahee, John W. Ostrominski, et al. · Obesity Science & Practice
PDF
The 1-year Effectiveness of a Remote Team-based Guideline Directed Medication Titration Program in Type 2 Diabetes at High Cardiovascular and Kidney Risk Compared With Standard of Care
2025 · Shahzad Hassan, Lee-Shing Chang, et al. · Journal of the American College of Cardiology
PDF
Long-term Blood Pressure Trends Following a Remote Hypertension Intervention
2024 · Shahzad Hassan, Alexander Blood, et al. · Journal of the American College of Cardiology
Enrollment strategies in the era of digital revolution: Experience from a remote health management program (Preprint)
2024 · Shahzad Hassan, Lee-Shing Chang, et al.
Abstract P114: Patient Preferences And Experiences With Cuffless Wrist Versus Upper Arm Cuff Blood Pressure Measurements In The CO ntinual Vs. O ccasiona L B lood P ressure Monitoring (COOL-BP) Study
2023 · Ozan Unlu, Simin Lee, et al. · Hypertension
Works count: 15
Citation count: 73
H-index: 5
I10-index: 1
Year
Topic
Type